LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 1 | G16 | 72 | hr | 1476 | 1695 | 3788 | 0.4474 | 0.1067 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 2 | G16 | 72 | hr | 1476 | 1597 | 3731 | 0.4280 | 0.0603 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP5 | 3 | G16 | 72 | hr | 1476 | 1485 | 3796 | 0.3911 | 0.0041 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP6 | 1 | G15 | 72 | hr | 1476 | 1134 | 3413 | 0.3322 | -0.1963 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP6 | 2 | G15 | 72 | hr | 1476 | 1331 | 3783 | 0.3518 | -0.0737 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP6 | 3 | G15 | 72 | hr | 1476 | 1237 | 3734 | 0.3313 | -0.1240 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 1 | G15 | 72 | hr | 1476 | 1506 | 3788 | 0.3975 | 0.0146 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 2 | G15 | 72 | hr | 1476 | 1322 | 3731 | 0.3543 | -0.0794 |
| SK-BR-3 | Withaferin A | 1.11 | uM | LJP5 | 3 | G15 | 72 | hr | 1476 | 1348 | 3796 | 0.3551 | -0.0648 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP6 | 1 | G14 | 72 | hr | 1476 | 829 | 3413 | 0.2429 | -0.3798 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP6 | 2 | G14 | 72 | hr | 1476 | 911 | 3783 | 0.2408 | -0.2994 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP6 | 3 | G14 | 72 | hr | 1476 | 762 | 3734 | 0.2041 | -0.3900 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP5 | 1 | G14 | 72 | hr | 1476 | 851 | 3788 | 0.2246 | -0.3333 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP5 | 2 | G14 | 72 | hr | 1476 | 854 | 3731 | 0.2289 | -0.3360 |
| SK-BR-3 | Withaferin A | 3.33 | uM | LJP5 | 3 | G14 | 72 | hr | 1476 | 783 | 3796 | 0.2062 | -0.3723 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP6 | 1 | G13 | 72 | hr | 1476 | 893 | 3413 | 0.2616 | -0.3404 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP6 | 2 | G13 | 72 | hr | 1476 | 995 | 3783 | 0.2630 | -0.2524 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP6 | 3 | G13 | 72 | hr | 1476 | 1079 | 3734 | 0.2890 | -0.2090 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP5 | 1 | G13 | 72 | hr | 1476 | 989 | 3788 | 0.2610 | -0.2554 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP5 | 2 | G13 | 72 | hr | 1476 | 960 | 3731 | 0.2573 | -0.2753 |
| SK-BR-3 | Withaferin A | 10 | uM | LJP5 | 3 | G13 | 72 | hr | 1476 | 872 | 3796 | 0.2297 | -0.3207 |
| SK-BR-3 | LJP6 | 1 | A03 | 72 | hr | 1476 | 2854 | 3413 | 0.8361 | 0.7248 | |||
| SK-BR-3 | LJP6 | 1 | A04 | 72 | hr | 1476 | 2863 | 3413 | 0.8388 | 0.7293 | |||
| SK-BR-3 | LJP6 | 1 | A05 | 72 | hr | 1476 | 2973 | 3413 | 0.8710 | 0.7841 | |||
| SK-BR-3 | LJP6 | 1 | A06 | 72 | hr | 1476 | 2220 | 3413 | 0.6504 | 0.4011 |